Krissie Lenting

Radioprotection of <i>IDH1</i> -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198

Remco J. Molenaar, Dennis Botman, Myrthe A J Smits et al. · Cancer Research · 2015 · 142 citations

<i>In silico</i> gene expression analysis reveals glycolysis and acetate anaplerosis in <i>IDH1</i> wild-type glioma and lactate and glutamate anaplerosis in <i>IDH1</i>-mutated glioma

Mohammed Khurshed, Remco J. Molenaar, Krissie Lenting et al. · Oncotarget · 2017 · 68 citations · Full text

Isocitrate dehydrogenase 1–mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress

Krissie Lenting, Mohammed Khurshed, Tom H. Peeters et al. · The FASEB Journal · 2018 · 44 citations

Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing

Krissie Lenting, Corina N. A. M. van den Heuvel, Anne van Ewijk et al. · Acta Neuropathologica Communications · 2019 · 30 citations · Full text

Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate

Tom H. Peeters, Krissie Lenting, Vincent Breukels et al. · Cancer & Metabolism · 2019 · 28 citations · Full text